Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy

W Grimm1, J Hoffmann, V Menz

  • 1Department of Cardiology, Hospital of the Philipps-University of Marburg, Germany.

Insights

Programmed ventricular stimulation (PVS) did not effectively predict arrhythmia risk in patients with idiopathic dilated cardiomyopathy (IDC) and nonsustained ventricular tachycardia (VT). The study lacked sufficient power to rule out moderate outcome differences between patients with and without inducible VT.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Background:

  • Nonsustained ventricular tachycardia (VT) in idiopathic dilated cardiomyopathy (IDC) is linked to increased sudden cardiac death risk.
  • Effective risk stratification is crucial for managing patients with IDC and spontaneous nonsustained VT.

Purpose of the Study:

  • To evaluate the utility of programmed ventricular stimulation (PVS) for predicting arrhythmia events in patients with IDC and nonsustained VT.
  • To assess the correlation between inducible sustained ventricular arrhythmias during PVS and subsequent arrhythmic events.

Main Methods:

  • 34 patients with IDC, reduced left ventricular ejection fraction (< or =35%), and spontaneous nonsustained VT underwent PVS.
  • Patients were prospectively followed for 24+/-13 months for arrhythmic events, including sudden cardiac death and ICD shocks.

Main Results:

  • Sustained ventricular arrhythmias were induced in 38% of patients (3% monomorphic VT, 29% polymorphic VT/ventricular fibrillation).
  • No significant difference in arrhythmic events was observed between patients with inducible (31%) and non-inducible (24%) sustained ventricular arrhythmias during follow-up.
  • Implantable cardioverter-defibrillators (ICDs) were implanted in all patients with inducible arrhythmias and 43% of those without.

Conclusions:

  • Programmed ventricular stimulation (PVS) does not appear to be a helpful tool for arrhythmia risk stratification in this patient cohort.
  • The study's limited sample size restricts definitive conclusions regarding PVS efficacy and the ability to exclude moderate outcome differences.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...